World Mexico, Brazil won't limit AstraZeneca vaccine after UK warning

06:15  08 april  2021
06:15  08 april  2021 Source:   thehill.com

How AstraZeneca's vaccine got mired in politics and mistrust to become Europe's least favorite shot

  How AstraZeneca's vaccine got mired in politics and mistrust to become Europe's least favorite shot A succession of communication blunders about the vaccine has led some Europeans to see it as second rate.Merkel's interview with the Frankfurter Allgemeine Zeitung came as governments across Europe realized that mistrust among its people for this particular shot imperiled the continent's entire vaccination drive.

MEXICO CITY (Reuters) - Mexico 's drug regulator said on Wednesday it has no current plans to limit use of AstraZeneca 's COVID-19 shot after Britain's vaccine advisory committee cited safety concerns over its use in people under age 30. The drug regulator, Cofepris, said in a statement that it is Mexico has so far acquired 3.5 million doses of the AstraZeneca vaccine developed with Oxford University researchers, according to government data. Some of that came through a loan deal with the United States, where the AstraZeneca shot is not yet authorized, and from an agreement with the

Brazil 's health regulator Anvisa met with AstraZeneca Plc representatives in the morning and said the company's local partners, federally-funded biomedical institute Fiocruz, will file for emergency use authorization, without saying when. Britain became the first country in the world to give full regulatory approval to the The U.S. warned Wednesday it won ’ t allow a Pakistani man who was convicted and later acquitted in the 2002 murder of American journalist Daniel Pearl to evade justice after a provincial court in Pakistan ordered his release. The warning from acting U.S. Attorney General Jeffrey Rosen

a close up of a bottle: Mexico, Brazil won't limit AstraZeneca vaccine after UK warning © Getty Images Mexico, Brazil won't limit AstraZeneca vaccine after UK warning

Mexico and Brazil do not plan on limiting access to AstraZeneca's COVID-19 vaccine after the United Kingdom's drug regulator recommended doing so amid a potential risk of blood clots.

The statements come after the U.K's Medicines and Healthcare Products Regulatory Agency (MHRA) recommended that the vaccine only be used in people over the age of 30 due to the potential link to rare blood clots.

The agency said it reviewed 79 reports of rare blood clots after the vaccine was administered, with 19 deaths. Eleven out of the 19 who died were under the age of 50, while three were under the age of 30.

U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted

  U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted San Diego State’s Klara Thormalm has been named the Mountain West Swimmer of the Year as voted on by the league’s coaches. Wyoming’s Melissa Mirafuentes was selected as the MW Diver of Year.

AstraZeneca ’s Covid-19 vaccine , Vaxzevria, should include a warning about the risk of blood clots as one of the jab’s very rare side effects, the EU’s drug regulator, the European Medicines Agency (EMA), has said. On Tuesday, Oxford University – which was involved in developing the inoculation with AstraZeneca – paused its trial of the vaccine in children while the UK regulator investigated a possible link between the jab and blood clots among some adult recipients. The World Health Organization’s committee on vaccine safety said in a statement on Wednesday that cases of blood clots linked to

UK under-30s will be offered other jabs amid evidence linking the AstraZeneca vaccine to blood clots. Under-30s are to be offered an alternative Covid jab to the AstraZeneca vaccine , the UK 's vaccine advisory body says. Advice for younger people is changing after an investigation into cases of blood clots in people who have had the jab. The vaccination programme has been "a most enormous success" but needs a "course correction", Prof Jonathan Van-Tam says.

Cofepris, Mexico's drug regulator, said that it is still reviewing the recommendations. However, it does "not plan to limit the use of AstraZeneca vaccines to any age or group," Reuters reported. Mexico has acquired 3.5 million doses of the vaccine so far.

Meanwhile, Brazil's health regulator Anvisa said the benefits of the vaccine outweighed its risk, and recommended its continued use. The news outlet noted that Brazil has administered over 4 million shots of the vaccine, and has only registered 47 clotting events.

The U.K.'s recommendation came the same day that the European Medicines Agency's (EMA) safety panel concluded that a "possible link" between rare blood clots and the vaccine existed.

Concerns over blood clots in a small number of patients resulted in over a dozen countries suspending the use of the vaccine last month. Oxford University paused a clinical trial testing the vaccine in 300 children ages 6 to 17 while it awaited the MHRA's opinion on the reports of blood clotting.

AstraZeneca has maintained that its evidence has not found a causal link between its vaccine and blood clotting.

"More than a panic wind": the AstraZeneca vaccine shuddered in the north of France .
in Boulogne-sur-Mer, Calais and Gravelines, the vaccination centers could not administer all their doses of the AstraZeneca vaccine . © Fred Tanneau / AFP A nurse vaccinates a healthy student with the AstraZeneca Covid-19 vaccine, on March 12, 2021 at the UBO (University of West Brittany) in Brest, in western France. The cases of thrombosis after receiving the AstraZeneca vaccine are very rare. The French Medicine Agency (ANSM) counts twelve, total, on several million injections.

usr: 0
This is interesting!